astrazeneca plc (AZNCF:OTC US)

Executive Profile*

Background*

Mr. Pascal Soriot has been the Chief Executive Officer at AstraZeneca PLC since October 1, 2012. Mr. Soriot served as the Chief Operating Officer of Roche Pharma AG until September 1, 2012. He served as the Chief Operating Officer of Roche Pharmaceuticals at Roche Diabetes Care AG. He served as the Chief Operating Officer of Pharmaceuticals at Roche Holding AG since January 1, 2010 and served as its Head of Pharma Medicines. Mr. Soriot served as the Chief Executive Officer ... of Genentech Inc. since 2009. He served as Head of Commercial Operations at Roche Holding AG since December 2006 and Head of Strategic Marketing Pharma division from March 1, 2006 to December 2006. Mr. Soriot served as Senior Vice President of Commercial Operations, United States of Sanofi-aventis since August 2004 and Chief Operating Officer since 2002. Before joining sanofi-aventis, Mr. Soriot served in a similar position at Aventis. After being appointed by Roussel Uclaf in 1986 as Financial Controller for the Asia-Pacific region, he held various management positions in finance and marketing at companies that form part of sanofi-aventis. He served as District Sales Manager at Roussel New Zealand since 1987. He served as Sales and Marketing Manager at Roussel Australia since 1989 and also served as its General Manager. He served as Division Global Marketing Director at Roussel Uclaf Pharmaceuticals since 1994 and General Manager at Hoechst Marion Roussel Australia since 1996. He served as Regional Vice President, Asia Pacific at Hoechst Marion Roussel Tokyo since 1997. He served as Senior Vice President and Head of Global Marketing & Medical Affairs at Aventis Bridgewater (US) since 2000, and Head of Strategic Marketing at Roche since 2006 and as its Head of Commercial Operations since 2007. He has been an Executive Director at AstraZeneca PLC since October 1, 2012. He served as a Director of Genentech, Inc. He served as a Director of Chugai Pharmaceutical Co. Ltd. until September 3, 2012. Mr. Soriot holds a Doctoral degree in Veterinary Medicine from the Ecole Nationale Vtrinaire at Maisons-Alfort and an MBA with major in Finance from HEC Paris (Ecole des Hautes Etudes Commerciales -- Institut Suprieur des Affaires).

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AZNCF:US	$51.10 USD	0.00

COMPETITOR COMPENSATION